These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37623025)
21. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765 [TBL] [Abstract][Full Text] [Related]
22. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate. Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296 [TBL] [Abstract][Full Text] [Related]
23. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022? Stiefel R; Lehmann K; Winder T; Siebenhüner AR BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152 [TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers]. Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792 [TBL] [Abstract][Full Text] [Related]
25. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Boudreaux JP; Klimstra DS; Hassan MM; Woltering EA; Jensen RT; Goldsmith SJ; Nutting C; Bushnell DL; Caplin ME; Yao JC; Pancreas; 2010 Aug; 39(6):753-66. PubMed ID: 20664473 [TBL] [Abstract][Full Text] [Related]
26. Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective. Kolasińska-Ćwikła A; Łowczak A; Maciejkiewicz KM; Ćwikła JB Nucl Med Rev Cent East Eur; 2018; 21(2):. PubMed ID: 29741203 [TBL] [Abstract][Full Text] [Related]
27. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres. Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035 [TBL] [Abstract][Full Text] [Related]
28. [Neuroendocrine tumors of the small bowels are on the rise: early tumors and their management]. Scherübl H; Schwertner C; Steinberg J; Stölzel U; Pohl J; Dralle H; Klöppel G Z Gastroenterol; 2010 Mar; 48(3):406-13. PubMed ID: 20183784 [TBL] [Abstract][Full Text] [Related]
29. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases. Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974 [TBL] [Abstract][Full Text] [Related]
30. Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours. Almeamar H; Cullen L; Murphy DJ; Crowley RK; Toumpanakis C; Welin S; O'Shea D; O'Toole D J Neuroendocrinol; 2022 Jun; 34(6):e13138. PubMed ID: 35485450 [TBL] [Abstract][Full Text] [Related]
31. Association between surveillance imaging and survival outcomes in small bowel neuroendocrine tumors. Watanabe A; Mckendry G; Yip L; Loree JM; Stuart HC J Surg Oncol; 2023 Mar; 127(4):578-586. PubMed ID: 36537012 [TBL] [Abstract][Full Text] [Related]
32. Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs. Lenotti E; Alberti A; Spada F; Amoroso V; Maisonneuve P; Grisanti S; Baggi A; Bianchi S; Fazio N; Berruti A Front Endocrinol (Lausanne); 2021; 12():669484. PubMed ID: 33986731 [TBL] [Abstract][Full Text] [Related]
33. Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand. McGuinness MJ; Woodhouse B; Harmston C; Parker K; Kramer N; Findlay M; Print C; Merrie A; Lawrence B ANZ J Surg; 2022 Jul; 92(7-8):1748-1753. PubMed ID: 35762209 [TBL] [Abstract][Full Text] [Related]
34. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival. Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611 [TBL] [Abstract][Full Text] [Related]
35. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors. Hallet J; Law C; World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557 [TBL] [Abstract][Full Text] [Related]
36. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less. Özaslan E; Karaca H; Koca S; Sevinç A; Hacioğlu B; Özkan M; Özçelik M; Duran AO; Hacibekiroğlu İ; Yildiz Y; Tanriverdi Ö; Menekşe S; Aksoy A; Bozkurt O; Urvay S; Uysal M; Demir H; Çiltaş A; Dane F Anticancer Drugs; 2017 Feb; 28(2):222-229. PubMed ID: 27768606 [TBL] [Abstract][Full Text] [Related]
37. Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Parghane RV; Talole S; Prabhash K; Basu S Clin Nucl Med; 2017 Jun; 42(6):428-435. PubMed ID: 28319500 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Katona BW; Roccaro GA; Soulen MC; Yang YX; Bennett BJ; Riff BP; Glynn RA; Wild D; Nicolas GP; Pryma DA; Teitelbaum UR; Metz DC Pancreas; 2017 Oct; 46(9):1121-1126. PubMed ID: 28902781 [TBL] [Abstract][Full Text] [Related]
39. The Evolving Landscape of Neuroendocrine Tumors. Russo A; Gangi A Surg Oncol Clin N Am; 2023 Jan; 32(1):185-198. PubMed ID: 36410917 [TBL] [Abstract][Full Text] [Related]
40. Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre. Bazarbashi S; Aseafan M; Elgazzar T; Alkhayat M; Alghabban A; Abdelgawad MI; Alshamsan B; Alshibany A; Elhassan T; Aljubran A; Alzahrani A; Alhindi H; Raef H BMC Endocr Disord; 2023 Apr; 23(1):74. PubMed ID: 37029347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]